We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comfort Evaluation of a New MPS vs. Replenish in Contact Lens Patients

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00518700
First Posted: August 21, 2007
Last Update Posted: April 24, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Innovative Medical
  Purpose
To compare corneal staining after contact lens instillation with a new MPS vs. RepleniSH

Condition Intervention Phase
Corneal Staining Other: new MPS Other: RepleniSH Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single (Investigator)

Resource links provided by NLM:


Further study details as provided by Innovative Medical:

Enrollment: 24
Study Completion Date: April 2008
Primary Completion Date: April 2008 (Final data collection date for primary outcome measure)
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Criteria

Inclusion Criteria:

  1. Patients 18 yrs or older
  2. Males or females
  3. Any race or ethnic background
  4. CL patients using MPS products currently
  5. Patients using Contact Lenses habitually (at least 1 month)

Exclusion Criteria:

  1. Corneal refractive surgery within 6 months of this study.
  2. Contact lens use on day of examination.
  3. Corneal ectasia.
  4. Current use of Restasis
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00518700


Locations
United States, California
Private Practice
Azusa, California, United States, 91702
Sponsors and Collaborators
Innovative Medical
Investigators
Principal Investigator: Milton Hom, OD, FAAO Private Practice
  More Information

Responsible Party: Innovative medical, Innovative Medical
ClinicalTrials.gov Identifier: NCT00518700     History of Changes
Other Study ID Numbers: 5321
First Submitted: August 17, 2007
First Posted: August 21, 2007
Last Update Posted: April 24, 2008
Last Verified: April 2008